康芝药业

300086 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

3.7B ($542.7M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

473.0M

Net Income

-224.0M

Gross Margin

N/A

Op. Margin

-46.9%

Net Margin

-47.4%

ROE

-19.2%

ROA

-11.3%

D/E

0.70

Dividend Yield

N/A

EPS

-0.47

Current Ratio

0.89

Price History

Company Info

Industry	C27医药制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks. It markets its products through a network of agents and sales terminals. Honz Pharmaceutical Co., Ltd. was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharma...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 康芝药业

Ticker	300086
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业